A critical deadline approaches for investors in Capricor Therapeutics, Inc., as the esteemed Rosen Law Firm encourages immediate action for those who acquired securities during a specific period.
The firm, a global advocate for Investor Rights, is drawing attention to the September 15, 2025, lead plaintiff deadline. This date is paramount for individuals who purchased Capricor Therapeutics (NASDAQ: CAPR) securities between October 9, 2024, and July 10, 2025, an identified ‘Class Period’ central to the ongoing Securities Lawsuit.
Selecting qualified Legal Counsel with a proven track record is strongly emphasized. The Rosen Law Firm highlights that many entities issuing similar notices may lack the necessary experience, extensive resources, or peer recognition essential for effective representation in complex securities litigation.
Unlike some intermediaries, the Rosen Law Firm is directly engaged in litigating Class Action cases, rather than merely referring clients. This direct involvement ensures that investors receive dedicated and experienced representation throughout the legal process, underscoring the firm’s commitment to Shareholder Protection.
With a global presence, The Rosen Law Firm specializes in securities class actions and shareholder derivative litigation. This focused approach has allowed the firm to achieve significant milestones and recover substantial sums for investors worldwide, reinforcing its position as a leader in this specialized legal field.
The firm’s notable achievements include securing what was, at the time, the largest securities class action settlement against a Chinese Company. Additionally, ISS Securities Class Action Services ranked Rosen Law Firm No. 1 for the number of securities class action settlements in 2017, consistently placing it among the top four firms annually since 2013.
Collectively, the firm has recovered hundreds of millions of dollars for investors, with an impressive $438 million secured in 2019 alone. Further solidifying its reputation, founding partner Laurence Rosen was recognized by Law360 as a ‘Titan of Plaintiffs’ Bar’ in 2020, with many other firm attorneys also receiving accolades from Lawdragon and Super Lawyers.
For investors impacted by the Capricor Therapeutics securities matter, understanding the deadline and choosing experienced legal counsel like the Rosen Law Firm is crucial to potentially recovering losses and upholding their investor rights.
